Evaluation of Different Weight Correction Methods for Antenatal Serum Screening Using Data from Two Multi-Centre Programmes
Open Access
- 1 May 1999
- journal article
- research article
- Published by SAGE Publications in Annals of Clinical Biochemistry: International Journal of Laboratory Medicine
- Vol. 36 (3) , 359-364
- https://doi.org/10.1177/000456329903600309
Abstract
Weight correction of serum markers is widely used when screening for Down's syndrome and open neural tube defects (NTD) because marker concentrations decrease with increasing maternal weight. Log-linear regression is frequently used for determining weight correction factors, but recently reciprocal-linear regression has been suggested to have advantages. We compared both methods of weight correction using data from two screening programmes carried out by this laboratory, one using α-fetoprotein (AFP) and total human chorionic gonadotrophin (HCG) (n = 129 143) and the other, AFP and free β-HCG (n = 39 982). The reciprocal-linear method fitted the data more closely but did not significantly alter the detection rate or screen positive rate (SPR) for Down's syndrome or NTD with either dataset. Without correction, women heavier or lighter than average weight had significantly different SPRs for Down's syndrome and NTD compared with those weighing close to the median weight. Both correction methods smoothed out the variability in the SPR for Down's syndrome to a similar degree, but reciprocal-linear regression was much better at reducing the variability in SPR for NTD and its use is therefore worthwhile.Keywords
This publication has 12 references indexed in Scilit:
- Alternative methods of maternal weight adjustment in maternal serum screening for Down syndrome and neural tube defectsPrenatal Diagnosis, 1998
- REFINEMENTS IN MANAGING MATERNAL WEIGHT ADJUSTMENT FOR INTERPRETING PRENATAL SCREENING RESULTSPrenatal Diagnosis, 1996
- Down's Syndrome Screening Using Free βhCG: Instability Can Significantly Increase the Down's Risk EstimateAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1996
- Risk‐based prenatal screening for trisomy 18 using alpha‐fetoprotein, unconjugated oestriol and human chorionic gonadotropinPrenatal Diagnosis, 1995
- Four‐marker serum screening for Down's syndromePrenatal Diagnosis, 1994
- Free Beta Human Choriogonadotropin in Down's Syndrome Screening: A Multicentre Study of its Role Compared with other Biochemical MarkersAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1992
- Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weightBJOG: An International Journal of Obstetrics and Gynaecology, 1992
- The Effect of Weight Correction on Risk Calculations for Down's Syndrome ScreeningAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1991
- The effect of adjusting maternal serum α-fetoprotein levels for maternal weight in pregnancies with fetal open spina bifidaAmerican Journal of Obstetrics and Gynecology, 1990
- THE EFFECT OF MATERNAL WEIGHT ON MATERNAL SERUM ALPHA‐FETOPROTEIN LEVELSBJOG: An International Journal of Obstetrics and Gynaecology, 1981